Article Sidebar

pdf
Issue: Vol. 562 No. 3 (2026)
Section: Các bài báo
DOI: 10.51298/vmj.v562i3.18618
Date Published: 13/08/2026
Views 0
Downloads 0
How to Cite
Cao C, T. N., Thạch , M. T., & Trịnh , T. P. D. (2026). LIPID PROFILE ABNORMALITIES IN HYPERTENSIVE PATIENTS AT THE NATIONAL HOSPITAL OF TRADITIONAL MEDICINE IN 2025. Vietnam Medical Journal, 562(3). https://doi.org/10.51298/vmj.v562i3.18618

LIPID PROFILE ABNORMALITIES IN HYPERTENSIVE PATIENTS AT THE NATIONAL HOSPITAL OF TRADITIONAL MEDICINE IN 2025

Thanh Ngoan Cao C1, , Minh Thư Thạch 2, Thị Phương Dung Trịnh 2,3
1 Bệnh viện Y học cổ truyền Hà Đông
2 Trường Đại học Y Hà Nội
3 Bệnh viện Bạch Mai

Main Article Content

Abstract

Background: Hypertension is a major public health concern and is strongly associated with cardiovascular disease and premature mortality. Dyslipidemia is an important risk factor that contributes to the development of atherosclerosis in hypertensive patients.


Objective: To investigate the characteristics of lipid abnormalities in hypertensive patients treated at the National Hospital of Traditional Medicine in 2025.


Methods: A cross-sectional descriptive study was conducted on 200 hypertensive patients and 200 non-hypertensive subjects at the National Hospital of Traditional Medicine from June to December 2025. Lipid parameters including total cholesterol (TC), triglycerides (TG), HDL-C, and LDL-C were measured using the Beckman Coulter AU480 system.


Results: The mean levels of TC, TG, and LDL-C were higher in the hypertensive group, while HDL-C was lower compared to the non-hypertensive group. The prevalence of dyslipidemia in the hypertensive group was 72.0%, significantly higher than in the control group (58.0%) (OR = 1.86; p = 0.003). The proportion of patients with ≥2 abnormal lipid components in the hypertensive group was 41.0%.


Conclusion: Dyslipidemia is common among hypertensive patients, particularly multi-component lipid abnormalities, which may contribute to an increased cardiovascular risk.

Keywords

Hypertension, dyslipidemia, cholesterol, triglycerides

Article Details

References

1. World Health Organization. Hypertension [Internet]. Geneva: WHO; 2023 [cited 2026 Apr 28]
2. Bộ Y tế. Điều tra quốc gia yếu tố nguy cơ bệnh không lây nhiễm (STEPS) Việt Nam năm 2015. Hà Nội: Bộ Y tế; 2016.
3. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC guideline on the management of blood cholesterol. Circulation. 2019;139(25):e1082–e1143.
4. Kannel WB, Dawber TR, Friedman GD, Glennon WE, McNamara PM. Risk factors in coronary heart disease: An evaluation of several serum lipids as predictors of coronary heart disease. Ann Intern Med. 1964;61:888–899.
5. Rosano GMC, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric. 2007;10 Suppl 1:19–24.
6. Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. Circulation. 1997;96(1):308–315.
7. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629–636.
8. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB Sr, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. Circulation. 2014;129(25 Suppl 2):S49–S73.